CYNTHIA ROGERS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care ALBUQUERQUE, NM NPI 1558788992

General Payments — all program years on this page

$790.17

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $527.93 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $527.9318

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Janssen Biotech, Inc. $210.6912
Takeda Pharmaceuticals U.S.A., Inc. $195.405
Novo Nordisk AS $121.841

By program year

Program yearAmountRecords
2021 $21.711
2022 $30.212
2023 $210.326
2024 $527.9318

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078383802 Janssen Biotech, Inc. $17.29 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078384028 Janssen Biotech, Inc. $19.29 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078384247 Janssen Biotech, Inc. $20.18 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078384533 Janssen Biotech, Inc. $18.07 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078384579 Janssen Biotech, Inc. $19.29 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078384774 Janssen Biotech, Inc. $18.16 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078384845 Janssen Biotech, Inc. $1.71 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078385031 Janssen Biotech, Inc. $19.84 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078385112 Janssen Biotech, Inc. $22.47 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078385231 Janssen Biotech, Inc. $20.09 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078385296 Janssen Biotech, Inc. $19.69 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078385344 Janssen Biotech, Inc. $14.61 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100272032 Novo Nordisk Inc $121.84 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137816192 Takeda Pharmaceuticals U.S.A., Inc. $19.88 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137816194 Takeda Pharmaceuticals U.S.A., Inc. $18.67 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137816196 Takeda Pharmaceuticals U.S.A., Inc. $16.18 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137816198 Takeda Pharmaceuticals U.S.A., Inc. $124.99 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137816200 Takeda Pharmaceuticals U.S.A., Inc. $15.68 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.